BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2015 5:56:00 PM | Browse: 730 | Download: 1228
Publication Name World Journal of Gastroenterology
Manuscript ID 13824
Country/Territory Hungary
Received
2014-09-03 08:24
Peer-Review Started
2014-09-04 14:09
To Make the First Decision
2014-10-14 16:51
Return for Revision
2014-10-17 21:47
Revised
2014-10-24 18:34
Second Decision
2014-11-27 21:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-12-01 13:49
Articles in Press
2014-12-01 14:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-01-26 14:46
Publish the Manuscript Online
2015-02-11 17:56
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe
Manuscript Source Invited Manuscript
All Author List Fanni Rencz, Márta Péntek, Martin Bortlik, Edyta Zagorowicz, Tibor Hlavaty, Andrzej Śliwczyński, Mihai M Diculescu, Limas Kupcinskas, Krisztina B Gecse, László Gulácsi and Peter L Lakatos
Funding Agency and Grant Number
Corresponding Author Péter L Lakatos, MD, DSc, PhD, 1st Department of Medicine, Semmelweis University, Korányi S. 2/A, H-1083 Budapest, Hungary. lakatos.peter_laszlo@med.semmelweis-univ.hu
Key Words Inflammatory bowel diseases; Ulcerative colitis; Biological therapy; Access; Europe; Central and Eastern; Crohn’s disease
Core Tip Great heterogeneity ranging up to 96-fold difference in access of inflammatory bowel diseases (IBD) patients to biologicals can be found across Central and Eastern Europe (CEE): Poland, Bulgaria, Romania, and the Baltic States have, to date, fallen behind Hungary, Slovakia and the Czech Republic. The following factors did not explain the considerable variations among the CEE countries: differences in prevalence and incidence, price of biologicals, total expenditure on health, geographical access, clinical guidelines, and cost-effectiveness results. We assume that health deterioration linked to IBD might be valued differently against other systemic inflammatory conditions in distinct countries which contributes to the great heterogeneity.
Publish Date 2015-02-11 17:56
Citation Rencz F, Péntek M, Bortlik M, Zagorowicz E, Hlavaty T, Śliwczyński A, Diculescu MM, Kupcinskas L, Gecse KB, Gulácsi L, Lakatos PL. Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe. World J Gastroenterol 2015; 21(6): 1728-1737
URL http://www.wjgnet.com/1007-9327/full/v21/i6/1728.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i6.1728
Full Article (PDF) WJG-21-1728.pdf
Full Article (Word) WJG-21-1728.doc
Manuscript File 13824-Review.docx
Answering Reviewers 13824-Answering reviewers.pdf
Copyright License Agreement 13824-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 13824-Language certificate.pdf
Peer-review Report 13824-Peer review(s).pdf
Scientific Misconduct Check 13824-CrossCheck.jpg
Scientific Editor Work List 13824-Scientific editor work list.pdf